Protecting Human Subjects in Research: Are Current Safeguards Adequate? AHRP Testimony submitted to Congressional Committee April 23, 2002 Vera Hassner Sharav, President, and John H. Noble, Jr., Ph.D., steering committee member, The Alliance for Human Research Protection (AHRP), before the Subcommittee on Public Health, Committee on Health, Education, Labor, &…
Beware of Avian Flu Hoax – Senate HELP Committee OK’s bill to Shield Drug / Vaccine Mfg Tue, 25 Oct 2005 Serious questions are being raised by physicians and knowledgable critics about the government’s bullying tactics to promote the vaccine business. The scare tactics used to promote mass vaccination against…
Spitzer Expands drug Probe: Johnson & Johnson / New FDA analysis Confirms SSRI Risks to Kids – WSJ Thu, 5 Aug 2004 A front page article in The Wall Street Journal reports that a second FDA analysis of 25 clinical trials of SSRI antidepressants in children was conducted after a…
Soldier’s Death Tied to Vaccines / Experimental Ebola vaccine attracts no volunteers Wed, 19 Nov 2003 Two civilian medical panels that looked into the death of 22-year old Army reservist, Rachel Lacy, agreed that the death was “probably” or “possibly” an adverse reaction to a vaccine. Since Specialist Lacy had…
Advisory Panel: What Protections for Children, fetuses, embryos? Wed, 30 Oct 2002 The Washington Post reports that the administration has issued a new charter for a federal advisory committee extending safeguards for human subjects to include embryos and fetuses along with children and adults. Whatever the intent of the Bush…
Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Sun, 11 Dec 2005 Two major cases of medical research fraud on each side of the Atlantic involve evidence of fraud and data tampering by pharmaceutical company giants. Both cases provide insight into the way in…
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P, New York, NY 10023 Tel. No: 212-595-8974, Fax No: 212-595-9086 ***PRESS BRIEFING 2/2/04*** Statement by Vera Hassner Sharav, President, AHRP The Alliance for Human Research Protection is convening this press conference because we believe a fair and…
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…
Pharma’s Pervasive Influence Corrupts Medicine both sides of Atlantic Tue, 4 Oct 2005 The focus of criticism in medicine has shifted from cost and barriers to access to treatments to an examination of the safety and benefit of current treatments. The pharmaceutical industry’s corrupting influence on physicians, academic researchers, the…
Drug safety Hearings-Sept-Congress/ FDA – Lilly Plans to Disclose Data Tue, 3 Aug 2004 A hearing about the possible connection between suicide and antidepressant drugs will be held on Aug 4, by the California Senate by Sen. Tom Torkalson, chairman of the Senate Task Force on Youth and Workplace Wellness…
FDA Issues Public Health Advisory Entitled Reports Of Suicidality in Pediatric Mon, 27 Oct 2003 The FDA issued a warning about the suicide risk for children prescribed an antidepressant of the SSRI class. These drugs have never been shown to be more effective than placebo for the treatment of depression–which…
Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT Sun, 14 Mar 2004 Former Director of the National Institutes of Health, Harold Varmus, MD, appeared before a blue ribbon panel convened by his former agency, ostensibly to shed light on conflict of interest at…
